Abstract

This 39-page report from a working party of the British Society for Antimicrobial Chemotherapy* should help not only those working in industry and regulatory authorities, but also members of ethics committees, and authors and editors of papers on the treatment of infection. It will also help prescribers assess clinical trials of antibiotics.